Similar articles

• The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.

  Withey RJ, Feng H, Cook D, Van Petten GR, Lettau HF. Withey RJ, et al. J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):187-96. J Clin Pharmacol New Drugs. 1971. PMID: 5211352 No abstract available.
• The physiologic availability of phenylbutazone tablets marketed in India.

  Manek SP, Tipnis HP, Kulkarni RD. Manek SP, et al. Int J Clin Pharmacol Ther Toxicol. 1981 Apr;19(4):163-7. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7263103
• The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.

  Van Petten GR, Feng H, Withey RJ, Lettau HF. Van Petten GR, et al. J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):177-86. J Clin Pharmacol New Drugs. 1971. PMID: 5211351 No abstract available.
• Bio-availability and its clinical implications.

  Richens A. Richens A. Trans Med Soc Lond. 1975;91:18-22. Trans Med Soc Lond. 1975. PMID: 800695 Review. No abstract available.
• [Recent advance in predicting oral bioavailability].

  Ma GL, Cheng YY. Ma GL, et al. Yao Xue Xue Bao. 2006 Oct;41(10):917-20. Yao Xue Xue Bao. 2006. PMID: 17184106 Review. Chinese. No abstract available.